P
Phytoform Labs
Phytoform Labs is a biotechnology company using new technologies to improve the sustainability of agriculture and to make food more nutritious
About Phytoform Labs
Phytoform Labs operates at the intersection of agriculture and biotechnology, focusing on the rapid development of resilient and sustainable crops. Utilizing advanced genome editing techniques and artificial intelligence, Phytoform Labs accelerates the breeding process by introducing new crop traits in days rather than months. The company's core technology ensures precision by editing only the target DNA without introducing any transgenes, making the process footprint-free. Phytoform Labs serves agricultural producers and researchers who are in urgent need of innovative solutions to enhance crop resilience and sustainability. The company operates in the global agricultural biotechnology market, leveraging a B2B business model. Revenue is generated through partnerships, licensing agreements, and direct sales of their genome editing solutions. Phytoform Labs is headquartered at Rothamsted Research in the UK and also has a presence at Greentown Labs in the United States.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- St Albans, United Kingdom
- Sector
- Food
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed9 investors entered at this stage
Eniac Ventures
Jeff Dean
Pale Blue Dot
Ian Hogarth
FTW Ventures
Refactor Capital
Wireframe Ventures
Fine Structure Ventures
Rick Bernstein
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Phytoform Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Phytoform Labs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.